Explore the full record of transactions filed by de Verneuil Vanina, Directeur Juridique. Director active across 1 companies, notably Vir Biotechnology, Inc.. Cumulatively, 2 filings have been recorded. Total volume traded: €50k. The latest transaction was disclosed on 24 February 2026 — Cession. Regulator: SEC (Form 4). All data is free.
2 of 2 declarations
de Verneuil Vanina is the Executive Vice President, General Counsel, and Corporate Secretary at Vir Biotechnology, Inc. She oversees the company's legal affairs and compliance, ensuring adherence to regulations. Her role is essential in protecting the company's interests and advising management on legal matters. Through her expertise, she contributes to risk management and informed decision-making.